DLJ14, a novel chemo-sensitization agent, enhances therapeutic effects of adriamycin against MCF-7/A cells both <i>in vitro</i> and <i>in vivo</i> - Concepedia

Concepedia

Publication | Open Access

DLJ14, a novel chemo-sensitization agent, enhances therapeutic effects of adriamycin against MCF-7/A cells both <i>in vitro</i> and <i>in vivo</i>

DOI Full Paper Access

11

Citations

30

References

2013

Year

Peng Zhang, Beibei Zheng, Hongyuan Wang, Jinhua Chen, Xinyong Liu, Xiuli Guo

Journal of Pharmacy and Pharmacology

Abstract

DLJ14 is a promising chemo-sensitization candidate for the reversal of multidrug resistance in cancers.

References

	Year	Citations

Page 1